![]() |
市場調查報告書
商品編碼
1662781
2030 年蛋白腖市場預測:依來源、形式、應用、最終用戶、地區進行全球分析Peptone Market Forecasts to 2030 - Global Analysis By Source (Plant Peptone, Animal Peptone, Microbial Peptone and Other Sources), Form, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球蛋白腖市場規模預計在 2024 年達到 1.5263 億美元,到 2030 年將達到 2.1572 億美元,預測期內複合年成長率為 6.5%。
蛋白腖是透過蛋白質部分水解而獲得的胜肽和胺基酸的水溶性混合物。它常用於微生物學和生物化學研究中,作為培養細菌、酵母菌和其他微生物的營養源。它提供氮、碳和胺基酸等必需的生長因子,這些因子對於實驗室培養中的微生物代謝和生長至關重要。蛋白腖常見於微生物生長實驗所使用的培養基。
根據印度品牌資產基金會統計,印度目前擁有5,000家生技公司,其中760家為核心公司,4,240家為新興企業。預計到 2024 年將達到約 10,000。
個人化醫療需求日益成長
蛋白腖是用於生物製藥(包括個人化治療)開發和生產的細胞培養基的重要組成部分。精準醫療強調根據個人基因圖譜實施個人化治療,這推動了對專業化、高品質細胞培養環境的需求。蛋白腖是支持細胞生長和蛋白質生產所需的營養素。這種對更有針對性和客製化治療的需求直接增加了對蛋白腖的需求,刺激了生物技術和製藥領域的市場擴張。
環境和道德問題
植物來源的蛋白腖引發了環境和道德問題,尤其是在使用動物源蛋白腖方面。問題包括動物福利、資源使用和潛在的污染風險。原料採購過程中產生的森林砍伐和用水都會對環境造成影響。道德問題主要集中在動物治療和生產的永續性。這些替代品可能會減少對傳統蛋白腖來源的依賴並限制某些行業的需求。
微生物生物技術進展
隨著微生物生物技術的進步,蛋白腖的生產將變得更加高效和具有成本效益,從而可以從各種來源生產高品質的蛋白腖。這項進步使得製藥、食品和飲料等產業以及生物基產品生產的發酵過程得到最佳化。此外,生物技術的創新推動了植物來源的合成和重組蛋白腖的開發,滿足了對永續和道德的替代品日益成長的需求。這些進步擴大了蛋白腖的應用和可用性,進一步推動了市場的成長。
替代產品的可用性
蛋白腖的替代品包括植物來源、酵母萃取物和化學成分明確的培養基。這些替代品具有降低動物源污染物風險和提高一致性等優點。此外,替代品可以滿足人們對純素和無殘忍產品日益成長的需求,從而鼓勵人們擺脫傳統的蛋白腖。這種競爭,加上對監管部門核准和替代品生產可擴展性的擔憂,可能會減緩蛋白腖的市場擴張。
COVID-19 疫情對蛋白腖市場產生了多方面的影響。雖然由於生物技術和製藥研究的活性化,特別是在疫苗開發和診斷測試方面的研究,對蛋白腖的需求激增,但市場也面臨挑戰。此外,一些研究計劃已暫時停止,影響了市場成長。儘管存在這些挫折,但在研究主導的蛋白腖需求強勁成長的推動下,整體市場仍表現出彈性。
預測期內,蛋白腖水市場預計將成長至最大
預計預測期內蛋白腖部分將佔據最大的市場佔有率。蛋白腖水是一種營養豐富的液體培養基,主要用於微生物學研究和診斷應用。它含有來自肉類和植物等蛋白質來源的蛋白腖,可提供細菌和真菌培養所必需的必需氨基酸和生長因子。它能夠支持多種微生物,這使得它成為任何微生物學實驗室的重要組成部分。
預計預測期內發酵部分將以最高的複合年成長率成長。
預計預測期內發酵部分將呈現最高的成長率。蛋白腖是發酵應用中不可或缺的成分,也是微生物生長所必需的胺基酸、胜肽和維生素的豐富來源。支持微生物在酵素、抗生素和生質燃料等生物基產品生產的開發。它在製藥、生物技術和食品生產等行業中發揮著重要作用,因為它對於高效的發酵過程至關重要。
預計預測期內亞太地區將佔據最大的市場佔有率。這是因為生物技術、製藥和研究領域對高品質胜肽的需求不斷增加。中國、日本、印度、韓國和東南亞等地區以其快速發展的醫療保健和生物技術領域而聞名,推動了對胜肽生產的投資不斷成長。主要企業包括生物技術公司和多肽製造商,例如 Sigma-Aldrich、Peptide Synthetics 和 Bachem,他們憑藉創新產品和服務主導著該地區。
在預測期內,受生物技術和生物製藥領域蓬勃發展的推動,北美預計將呈現最高的複合年成長率。該地區是主要企業的所在地,包括賽默飛世爾科技、默克集團和 Soravia 集團。該地區成熟的研究基礎設施,加上在生命科學和醫療保健領域的大量投資,為北美蛋白腖市場的持續成長提供了肥沃的土壤。
According to Stratistics MRC, the Global Peptone Market is accounted for $152.63 million in 2024 and is expected to reach $215.72 million by 2030 growing at a CAGR of 6.5% during the forecast period. Peptone is a water-soluble mixture of peptides and amino acids derived from the partial hydrolysis of proteins. It is commonly used in microbiological and biochemical research as a nutrient source for cultivating bacteria, yeast, and other microorganisms. They provide essential growth factors, such as nitrogen, carbon, and amino acids, which are vital for the metabolism and proliferation of microorganisms in laboratory cultures. Peptones are frequently found in culture media for microbial growth experiments.
According to the India Brand Equity Foundation, there are currently 5,000 biotech businesses in the country, of which, 760 are core businesses and 4,240 are start-ups. By 2024, it is anticipated that there will be about 10,000 businesses.
Rising demand for personalized medicine
Peptones are essential components in cell culture media used for the development and production of biopharmaceuticals, including personalized therapies. As personalized medicine focuses on tailoring treatments based on individual genetic profiles, there is an increasing need for specialized, high-quality cell culture environments. Peptones provide the necessary nutrients to support cell growth and protein production. This demand for more targeted and customized therapies directly increases the need for peptones, fueling market expansion in the biotechnology and pharmaceutical sectors.
Environmental and ethical issues
Peptones, derived from animal or plant sources, raise environmental and ethical concerns, particularly regarding the use of animal-derived peptones. Issues include animal welfare, resource use, and potential contamination risks. Environmental impacts stem from deforestation and water usage associated with sourcing materials. Ethical concerns center on the treatment of animals and the sustainability of production. These alternatives may reduce reliance on traditional peptone sources, limiting demand in certain industries.
Advancements in microbial biotechnology
As microbial biotechnology improves, the production of peptones becomes more efficient and cost-effective, enabling the creation of high-quality peptones from various sources. This progress allows for better optimization of fermentation processes in industries like pharmaceuticals, food, and beverages, as well as in the production of bio-based products. Additionally, biotechnology innovations enable the development of plant-based, synthetic, or recombinant peptones, catering to growing demands for sustainable and ethical alternatives. These advancements expand the applications and availability of peptones, further driving market growth.
Availability of alternatives
Alternatives to peptones include plant-based extracts, yeast extracts, and chemically defined media. These alternatives offer advantages like reduced risk of animal-derived contaminants and greater consistency. Additionally, alternatives may cater to the growing demand for vegan and cruelty-free products, prompting industries to shift away from traditional peptones This competition, coupled with concerns over regulatory approvals and production scalability of alternatives, can slow down the market expansion for peptones.
The covid-19 pandemic had a mixed impact on the peptone market. While the demand for peptones surged due to increased biotechnology and pharmaceutical research, especially for vaccine development and diagnostic tests, the market also faced challenges. Additionally, some research projects were temporarily halted, affecting market growth. Despite these setbacks, the overall market showed resilience with a significant increase in research-driven demand for peptones.
The peptone water segment is expected to be the largest during the forecast period
The peptone segment is expected to account for the largest market share during the forecast period. Peptone water is a nutrient-rich liquid medium used primarily in microbiological research and diagnostic applications. It contains peptones, which are derived from protein sources like meat or plant matter, providing essential amino acids and growth factors for bacterial and fungal cultivation. Its ability to support a wide range of microorganisms makes it vital in microbiology laboratories.
The fermentation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the fermentation segment is predicted to witness the highest growth rate. Peptone is a vital ingredient in fermentation applications, serving as a rich source of amino acids, peptides, and vitamins essential for microbial growth. It supports the development of microorganisms in the production of bio-based products like enzymes, antibiotics, and biofuels. Its role is critical in industries such as pharmaceuticals, biotechnology, and food production, making it indispensable for efficient fermentation processes.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to the rising demand for high-quality peptides used in biotechnology, pharmaceuticals, and research. Regions such as China, Japan, India, South Korea, and Southeast Asia are well known for their rapidly developing healthcare and biotech sectors, contributing to increased investment in peptide production. Key players including biotechnology firms, and peptide manufacturers, such as Sigma-Aldrich, Peptide Synthetics, and Bachem, dominates the regional landscape with innovative products and services.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by the thriving biotechnology and biopharmaceutical sectors. The region is home for several key players such as Thermo Fisher Scientific, Merck KGaA, and Solabia Group which dominate the market. The region's well-established research infrastructure, coupled with significant investments in life sciences and healthcare, provides a fertile ground for the continued growth of the North American peptone market.
Key players in the market
Some of the key players in Peptone market include Thermo Fisher Scientific, Merck KGaA, Sigma-Aldrich, BD Biosciences, Neogen Corporation, HiMedia Laboratories, DuPont, Hardy Diagnostics, MP Biomedicals, Proliant Biologicals, Kerry, Inc., Solabia Group, Global BioIngredients Inc., Titan Biotech Limited, Biotecnica, Wako Pure Chemical Industries and Nu-Tek BioSciences.
In September 2024, Nu-Tek BioSciences launched two new versions of their Soy Peptone, specifically designed to meet the diverse needs of cell culture media applications. These new offerings expand Nu-Tek's portfolio of animal-free, non-GMO soy peptones, which are widely used in microbiological media, fermentation nutrient systems, and cell culture media.
In November 2021, Biotecnica introduced a new line of low endotoxin peptones. Biotecnica's new line of low endotoxin peptones eliminates the need for ultrafiltration, making the process more efficient and cost-effective. This development could help Biotecnica stand out in the competitive market of peptone suppliers by offering a product that addresses both technical and economic challenges in cell culture and microbiology applications.